今年6月7日,渤健(Biogen)基于β-淀粉样蛋白假说而开发的第一款用于治疗AD的单克隆抗体药物Aduhelm历经波折,终获得美国FDA批准上市,是近20年来AD领域首款新疗法...查看全文
$Translational(TDAC)$ SEC STAFF ACTION SEC Staff Action: ORDER Accession Number: 9999999997-23-004368 Size: 6 KB 网页链接
$Lottery.com(TDAC)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001104659-22-095195 Act: 33 Size: 3 MB 网页链接
$Trident(TDAC)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001213900-21-055467 Act: 34 Size: 286 KB 网页链接
$Trident(TDAC)$ 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0001354457-21-001247 Act: 34 Size: 2 KB 网页链接
$Trident(TDAC)$ 8-K Current report, item 5.07 Accession Number: 0001213900-21-055114 Act: 34 Size: 289 KB 网页链接
$Trident(TDAC)$ 425 Prospectuses and communications, business combinations Accession Number: 0001213900-21-053974 Act: 34 Size: 22 KB 网页链接
$Trident(TDAC)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001213900-21-053112 Act: 33 Size: 17 MB 网页链接
$Trident(TDAC)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-21-003897 Act: 33 Size: 1 KB 网页链接
$Trident(TDAC)$ 425 Prospectuses and communications, business combinations Accession Number: 0001213900-21-051709 Act: 34 Size: 35 KB 网页链接
$Trident(TDAC)$ S-4/A [Amend] Registration of securities, business combinations Accession Number: 0001213900-21-051465 Act: 33 Size: 17 MB 网页链接